Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisMattía Galli, Dominick J. Angiolillo, Stefano Benenati et al.|The Lancet|2021Cited by 229
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattía Galli, Dominick J. Angiolillo, Behnood Bikdeli et al.|European Heart Journal|2021Cited by 150
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary InterventionDominick J. Angiolillo, Dirk Sibbing, Mattía Galli et al.|JACC: Cardiovascular Interventions|2024Cited by 93
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trialsLuis Ortega‐Paz, Dominick J. Angiolillo, Mattía Galli et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2021Cited by 72
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysisMattía Galli, Dominick J. Angiolillo, Renzo Laborante et al.|Thrombosis and Haemostasis|2023Cited by 62